News and Events Recent News Aug 11, 2020 Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis Aug 5, 2020 Arrowhead Pharmaceuticals Reports Fiscal 2020 Third Quarter Results Jul 29, 2020 Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890 View More » Recent Events Aug 5, 2020 Arrowhead Pharmaceuticals 2020 Third Quarter Results Jul 28, 2020 ARO-ENaC KOL Webinar Jun 10, 2020 Goldman Sachs 41st Annual Global Healthcare Conference View More »
Aug 11, 2020 Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
Jul 29, 2020 Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890